Holen Sie sich die Stockscreener-App
1.90
0.00%
0.00
Handel nachbörslich:
1.91
0.01
+0.53%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DRRX?
Forum
Prognose
Aktiensplit
Durect Corp Aktie (DRRX) Neueste Nachrichten
When is the best time to exit DURECT CorporationPortfolio Value Summary & Accurate Buy Signal Alerts - Newser
Reversal indicators forming on DURECT Corporation stock2025 Sector Review & Growth Oriented Trade Recommendations - Newser
DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - 선데이타임즈
Will DURECT Corporation continue its uptrendQuarterly Market Review & Verified Entry Point Signals - Newser
Sentiment analysis tools applied to DURECT Corporation2025 Volatility Report & Growth-Oriented Investment Plans - Newser
Durect: Q2 Earnings Snapshot - Connecticut Post
Can swing trading help recover from DURECT Corporation losses [Portfolio Profit Report]Weekly Top Gainers Trade List - Newser
Published on: 2025-08-12 20:28:09 - Newser
Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
DURECT (DRRX) Reports Q2 2025 Results, Press Release Attached | DRRX SEC FilingForm 8-K - Stock Titan
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
Market reaction to DURECT Corporation’s recent newsMomentum-Based Prediction for Quick Returns - Newser
Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser
Technical signs of recovery in DURECT CorporationTechnical Insight Guide for Safer Trades - Newser
How is DRRX performing? - AInvest
Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser
Using data tools to time your DURECT Corporation exitEquity Performance Forecast Based on AI Models - Newser
DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Signal strength of DURECT Corporation stock in tech scannersReal-Time Entry Forecast with Accuracy Metrics - Newser
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey
Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest
Using R and stats models for DURECT Corporation forecastingAlpha Generation Strategy with Low Volatility - Newser
Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser
What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News
Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress
What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser
Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser
Bausch Health files SC TO-C ahead of tender offer for DURECT (DRRX) | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health expands liver disease portfolio with DURECT Corp buy - The Pharma Letter
Can swing trading help recover from DURECT Corporation lossesSwing Watchlist With Tight Stop Placement - Newser
What does recent volatility data suggest for DURECT CorporationLow Risk High Confidence Watchlist Builder - Newser
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Durect Corp: Analyzing DRRX Stock Trends - investchronicle.com
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside - FinancialContent
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - inkl
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views - Benzinga
Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell data - Endpoints News
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings - Benzinga
Bausch Health stock rises, Durect flies after acquisition deal By Investing.com - Investing.com Canada
Bausch Health stock rises, Durect flies after acquisition deal - Investing.com
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders - Business Wire
Durect stock rises on M&A deal with Bausch Health (BHC:NYSE) - Seeking Alpha
DRRX to be acquired by Bausch for $1.75 cash + CVR worth up to $350M | DRRX SEC FilingForm 8-K - Stock Titan
Bausch Health To Acquire DURECT; Expanding Liver Disease Pipeline With Larsucosterol - Nasdaq
Bausch Health to acquire DURECT in $63 million deal for liver disease drug - Investing.com Canada
Bausch Health to acquire DURECT for $63 million upfront By Investing.com - Investing.com Canada
Bausch Health to launch tender offer for DURECT; Schedule TO-C filed | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire
When is the best time to exit AA Mission Acquisition Corp.Free Community Shared Smart Money Signals - Newser
Is ICF International Inc. stock overhyped or has real potentialFree Low Risk Buy Zone Opportunity Watch - Newser
1.29%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):